These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8187296)

  • 21. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
    Chan JY; Walfish PG
    J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic aspects of thyroid disease.
    Riddick FA
    Ophthalmology; 1981 Jun; 88(6):471-5. PubMed ID: 6267533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of autoantibodies against thyroid peroxidase in autoimmune thyroid disease: evidence against antibodies directly inhibiting peroxidase activity as regulatory factors in thyroid hormone metabolism.
    Saller B; Hörmann R; Mann K
    J Clin Endocrinol Metab; 1991 Jan; 72(1):188-95. PubMed ID: 1702446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.
    Mariotti S; Caturegli P; Barbesino G; Marinò M; Del Prete GF; Chiovato L; Tonacchera M; De Carli M; Pinchera A
    Clin Endocrinol (Oxf); 1992 Nov; 37(5):415-22. PubMed ID: 1486691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
    Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
    J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-perinuclear and rheumatoid factor in different forms of autoimmune thyroid disease.
    Scherbaum WA; Youinou PY; Le Goff P; Bottazzo GF
    Clin Exp Immunol; 1984 Mar; 55(3):516-8. PubMed ID: 6608424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to Yersinia enterocolitica serotype 3 in autoimmune thyroid diseases.
    Takuno H; Sakata S; Miura K
    Endocrinol Jpn; 1990 Aug; 37(4):489-500. PubMed ID: 2083529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticardiolipin antibodies in Hashimoto's disease.
    Osundeko O; Hasinski S; Rose LI
    Endocr Pract; 2001; 7(3):181-3. PubMed ID: 11421564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of oral tolerance in human autoimmune thyroid disease.
    Lee S; Scherberg N; DeGroot LJ
    Thyroid; 1998 Mar; 8(3):229-34. PubMed ID: 9545109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease.
    Nagamine T; Takehara K; Fukui T; Mori M
    Clin Chim Acta; 1994 Apr; 226(1):47-54. PubMed ID: 7915219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of anti-thyroid plasma membrane antibody in patients with various thyroid diseases by solid phase enzyme-immunoassay].
    Iitaka M
    Nihon Naibunpi Gakkai Zasshi; 1984 Jul; 60(7):881-91. PubMed ID: 6389194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thyroid antibodies in autoimmune diseases of the thyroid and their dependence on the presence of autoantigens].
    Kriukova IV; Bazarova EN; Biriukova MP; Konnova EV; Okeanova TA
    Probl Endokrinol (Mosk); 1989; 35(4):19-22. PubMed ID: 2602346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of immunoregulatory T cells in human thyroid autoimmunity: influence of thyroid status.
    Bonnyns M; Bentin J; Devetter G; Duchateau J
    Clin Exp Immunol; 1983 Jun; 52(3):629-34. PubMed ID: 6223729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentration of soluble Fas in patients with autoimmune thyroid diseases.
    Shimaoka Y; Hidaka Y; Okumura M; Takeoka K; Tada H; Amino N
    Thyroid; 1998 Jan; 8(1):43-7. PubMed ID: 9492152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of nonthyroid specific autoantibodies in autoimmune thyroid diseases.
    Morita S; Arima T; Matsuda M
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1203-6. PubMed ID: 7714090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-nuclear antibody, anti-DNA, and aCL in Graves' disease patients treated with propyluracil or methimazole.
    Huang CN; Hsu TC; Chou HH; Tsay GJ
    Lupus; 2004; 13(6):450-4. PubMed ID: 15303572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease.
    Gilmour J; Brownlee Y; Foster P; Geekie C; Kelly P; Robertson S; Wade E; Braun HB; Staub U; Michel G; Lazarus JH; Parkes AB
    Clin Lab; 2000; 46(1-2):57-61. PubMed ID: 10745983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.